Mr Edward Lewis Wyant, RPH in Medford, OR - Pharmacist

Mr Edward Lewis Wyant, RPH is a Pharmacist based in Medford, Oregon. Mr Edward Lewis Wyant is licensed to practice in Oregon (license number 9432) and his current practice location is 2825 E Barnett Rd, Medford, Oregon. He can be reached at his office (for appointments etc.) via phone at (541) 789-4251.

NPI number for Mr Edward Lewis Wyant is 1003897612 and his current mailing address is 8801 John Day Dr, Gold Hill, Oregon. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1003897612.

Contact Information

	Mr Edward Lewis Wyant, RPH
	2825 E Barnett Rd, Medford, OR 97504-8332
	(541) 789-4251
	Not Available

Healthcare Provider's Profile

Full Name	Mr Edward Lewis Wyant
Gender	Male
Speciality	Pharmacist
Location	2825 E Barnett Rd, Medford, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1003897612
Provider Enumeration Date: 11/10/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mr Edward Lewis Wyant such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003897612	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	9432 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Edward Lewis Wyant is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Edward Lewis Wyant, RPH 8801 John Day Dr, Gold Hill, OR 97525-5525 Ph: (541) 855-7512	Mr Edward Lewis Wyant, RPH 2825 E Barnett Rd, Medford, OR 97504-8332 Ph: (541) 789-4251

News Archive

Oxytocin helps humans accept others, study finds

Oxytocin - often referred to as the 'love hormone' because of its ability to promote mother-infant attachment and romantic bonding in adults - could also make us more accepting of other people, as found in new research, "Oxytocin Sharpens Self-other Perceptual Boundary," by Neuropsychoanalysis Foundation research grantee Valentina Colonnello Ph.D. published online today in Psychoneuroendocrinology.

People in low-income areas experience more penetrating injuries than those in high-income regions: Study

Penetrating injury rates were more than 20 times higher for persons living in the lowest income neighborhoods compared with those living in the highest income neighborhoods, according to a new study published in the August issue of the Journal of the American College of Surgeons. Researchers also found that those in the lowest-income neighborhoods experienced nearly six times higher rates of blunt injury than persons in the highest income neighborhoods. Penetrating injuries included those from firearms or cuts; blunt injuries included motor vehicle crashes, falls and assaults.

Studies examine H1N1 treatment, outcome differences in Mexico, Canada

New studies suggest that "[d]eveloping countries with limited access to advanced health-care facilities may be in for a rough ride with swine [H1N1] flu and even countries with high-tech ICUs may find themselves pushed to the limit as their hospitals struggle to save gravely ill H1N1 patients," the Canadian Press reports.

Study identifies major osteoporosis knowledge gaps for some patient groups

A fracture in a person over the age of 50 can be a sign of osteoporosis, yet some patient populations have little knowledge of the disease. According to a groundbreaking study published in a recent Journal of Bone and Joint Surgery (JBJS), male and non-English speaking patients tend to have the least knowledge of osteoporosis, putting them at high risk for a subsequent fracture.

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.

Pharmacist in Medford, OR

Mr. Mark K Williams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Crater Lake Hwy, T-00613, Medford, OR 97504 Phone: 541-779-5110 Fax: 541-779-5110
Greg Alan Bryan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3639 Crater Lake Hwy, Pharmacy, Medford, OR 97504 Phone: 541-734-2482 Fax: 541-734-3209
Brandon Schmidt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1416 Britt Dr, Medford, OR 97501 Phone: 541-441-1910
Emily Siegrist, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 E Barnett Rd, Medford, OR 97504 Phone: 541-789-4460
Tiffany Hoenke, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 E Barnett Rd, Medford, OR 97501 Phone: 541-858-3336
Mr. Benjamin Egendoerfer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 E Barnett Rd, Medford, OR 97501 Phone: 541-858-3336

Mr Edward Lewis Wyant, RPH - Pharmacist in Medford, OR